NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jianzhong Hu
St. Jude Children's Research Hospital - Memphis / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 5698329
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jianzhong Hu's MOST POPULAR ARTICLES
1-)
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemiaY Gocho, J Liu, J Hu, W Yang, NV Dharia, J Zhang, H Shi, G Du, A John, ...Nature cancer 2 (3), 284-299, 2021912021
2-)
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemiaJ Hu, J Jarusiewicz, G Du, G Nishiguchi, S Yoshimura, JC Panetta, Z Li, ...Science translational medicine 14 (659), eabo5228, 2022112022
3-)
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemiaS Yoshimura, JC Panetta, J Hu, L Li, Y Gocho, G Du, A Umezawa, ...Leukemia 37 (6), 1194-1203, 202352023
4-)
Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screensS Wright, J Hu, H Wang, J Hyle, Y Zhang, G Du, MY Konopleva, ...Proceedings of the National Academy of Sciences 120 (16), e2220134120, 202372023
5-)
Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic LeukemiaK Tan, J Xu, C Chen, T Vincent, P Pölönen, J Hu, S Yoshimura, W Yu, ...Research Square, 202332023
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept